Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Inventory (2016 - 2025)

IGC Pharma (IGC) has disclosed Inventory for 14 consecutive years, with $658000.0 as the latest value for Q3 2025.

  • Quarterly Inventory fell 56.42% to $658000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $658000.0 through Sep 2025, down 56.42% year-over-year, with the annual reading at $1.4 million for FY2025, 11.69% down from the prior year.
  • Inventory for Q3 2025 was $658000.0 at IGC Pharma, down from $1.3 million in the prior quarter.
  • The five-year high for Inventory was $5.5 million in Q3 2021, with the low at $15000.0 in Q3 2023.
  • Average Inventory over 5 years is $1.9 million, with a median of $1.5 million recorded in 2024.
  • The sharpest move saw Inventory plummeted 99.6% in 2023, then soared 9966.67% in 2024.
  • Over 5 years, Inventory stood at $511000.0 in 2021, then plummeted by 89.24% to $55000.0 in 2022, then skyrocketed by 3400.0% to $1.9 million in 2023, then fell by 25.56% to $1.4 million in 2024, then plummeted by 54.08% to $658000.0 in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $658000.0, $1.3 million, and $1.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.